2016 ACR/ARHP Annual Meeting

November 11-16, 2016. Washington, DC.

View by Number View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l m n o p q r s t u v [w] x y z

Abstract Number: 2399

Waning Hepatitis B Immunity Status in a Significant Proportion of Immunocompromised Pediatric Rheumatology and Gastroenterology Patients
Abstract Number: 1482

Web-Based PILOT Intervention Study to Improve Cardiovascular Risk Knowledge Among Rheumatoid Arthritis Patients
Abstract Number: 3069

Weight Loss in the Early Rheumatoid Arthritis Period Is Associated with Subsequent Increased Mortality in RA Patients and Matched Comparators: Evidence Against an RA-Specific Obesity Paradox
Abstract Number: 2471

What Are the Reasons of Discrepancies Between Patients and Physicians in Their Perceptions of Rheumatoid Arthritis Disease Activity and What Is the Impact of This Discordance on Remission, Function and Structure at 1 Year?
Abstract Number: 2179

What Are the Risk Factors for Knee Pain, Radiographic Knee Osteoarthritis and Total Knee Replacement in Professional Footballers?
Abstract Number: 8

What Factors Relate to Patients Contributing Longitudinal Data Using Smartphone Technology? Findings from RA Patients Participating in Arthritispower Registry
Abstract Number: 785

What Is the Prevalence of Cognitive Impairment in Lupus and Which Instruments Are Used to Measure It? a Systematic Review and Meta-Analysis
Abstract Number: 538

What Is the Relationship Between Early Metacarpophalangeal Erosions on MRI and Joint Pain in Rheumatoid Arthritis?
Abstract Number: 3158

What Predicts Absence of Spinal Damage in Patients with Spondyloarthritis after Prolonged Follow up?
Abstract Number: 533

What Proportion of Patients Fail to Achieve CDAI and SDAI Remission Based on Physician Global Assessment? an Analysis from the Prospective, Observational Registry
Abstract Number: 3095

What Should be the Primary Target of ‘Treat to Target’ in Psa?
Abstract Number: 945

When and Where Musculoskeletal Ultrasound Might Replace Magnetic Resonance in the Assessment of Patients with Juvenile Idiopathic Arthritis?
Abstract Number: 148

Which Are the Ultrasound Lesions Underlying Dactylitis?
Abstract Number: 2709

Which Cells Correspond to the Typical Signals for Fatty and Inflammatory Lesions Seen in Magnetic Resonance Imaging in Ankylosing Spondylitis ? -a Prospective Study Using Biopsy Material Obtained during Spinal Surgery-
Abstract Number: 1984

Which Factors Associate with Localized Knee Pain and Generalized Pain: A 10-Year Longitudinal Study?
Abstract Number: 682

Which Is the Most Reliable Imaging Method for Detection of Structural Changes in the Sacroiliac Joints of Patients with Ankylosing Spondylitis? a Cross-Sectional Study Comparing MRI, CT and Conventional Radiographs
Abstract Number: 78

Whole Blood Gene Modules Show Differences Between Active Lupus Nephritis and Quiescent Disease As Well As Absence of Plasmablast Signature in This Adult Population
Abstract Number: 2862

Whole Blood Phenotyping and Innate and Adaptive Stimulation Reveal Unique Differences in Granulocytes and Innate Pathways of African American SLE Patients with Variable Disease Activity
Abstract Number: 2036

Whole Exome Sequencing in Early Onset Systemic Lupus Erythematosus
Abstract Number: 2667

Whole Frequency Audiometrical Correlation with Disease Activity in Primary SjöGren’s Syndrome in Hispanic Population
Abstract Number: 802

Whole Transcriptome Profiling through RNA Sequencing Reveals Differentially Expressed Sense-Antisense Gene Pairs in Patients with Systemic Sclerosis
Abstract Number: 431

Wide Variations in Hepatitis B Screening Practices for Patients Receiving Rituximab
Abstract Number: 2995

WISP1/CCN4 Aggravates Experimental Osteoarthritis and Is Associated with Disease Progression in Early Osteoarthritis Patients
Abstract Number: 766

Withdrawal of Mycophenolate Mofetil after Maintenance Treatment of SLE Nephritis Associated with Renal Relapse
Abstract Number: 2657

Withdrawal of Nonsteroidal Anti-Inflammatory Drugs in Rheumatoid Arthritis Patients with Low Disease Activity
Abstract Number: 35

WITHDRAWN
Abstract Number: 287

WITHDRAWN
Abstract Number: 384

WITHDRAWN
Abstract Number: 623

WITHDRAWN
Abstract Number: 778

WITHDRAWN
Abstract Number: 1659

WITHDRAWN
Abstract Number: 2207

WITHDRAWN
Abstract Number: 2209

WITHDRAWN
Abstract Number: 2210

WITHDRAWN
Abstract Number: 2212

WITHDRAWN
Abstract Number: 2214

WITHDRAWN
Abstract Number: 2215

WITHDRAWN
Abstract Number: 2216

WITHDRAWN
Abstract Number: 47

WITHDRAWN
Abstract Number: 180

WITHDRAWN
Abstract Number: 454

WITHDRAWN
Abstract Number: 476

WITHDRAWN
Abstract Number: 569

WITHDRAWN
Abstract Number: 1012

WITHDRAWN
Abstract Number: 1270

WITHDRAWN
Abstract Number: 1277

WITHDRAWN
Abstract Number: 1390

WITHDRAWN
Abstract Number: 1772

WITHDRAWN
Abstract Number: 1847

WITHDRAWN
Abstract Number: 1996

WITHDRAWN
Abstract Number: 2211

WITHDRAWN
Abstract Number: 51

WITHDRAWN
Abstract Number: 2119

Wogonin, a Plant-Derived Flavonoid, Exert Anti-Inflammatory and Chondroprotective Effects through the Activation Nrf2/HO-1 Signaling in Human OA Chondrocytes
Abstract Number: 2670

Work Disability in Newly Diagnosed Patients with Primary SjöGren’s Syndrome – a Population-Based Cohort Study
Abstract Number: 2479

Work Productivity in Early Rheumatoid Arthritis Patients Treated before and after Implementation of a Treat-to-Target Strategy
Abstract Number: 2910

Work Productivity in Systemic Sclerosis and Association with Health Related Quality of Life
Abstract Number: 549

Work Status in Patients with Rheumatoid Arthritis Who Have Poor Prognostic Factors: Findings from a US Observational Cohort
Abstract Number: 1570

Working in Cold Environment Is Associated with Increased Risk of Developing Rheumatoid Arthritis: Results from a Swedish Population-Based Case-Control Study

Jump to: View All • a b c d e f g h i j k l m n o p q r s t u v [w] x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].